ClinicalTrials.gg
Active, not recruitingNCT07036562TREHIIT-3Updated Aug 13, 2026

Time-restricted Eating and High-intensity Interval Training for Metabolic Health in Adults With Overweight/Obesity

An interventional study of Time-restricted eating and high-intensity interval training in Overweight and Obesity, sponsored by Norwegian University of Science and Technology. Active, not recruiting at 1 site in Norway. Open to participants aged 18 Years to 50 Years. Per ClinicalTrials.gov, last updated 2026-08-13.

Primary conditionObesityRegistry: OverweightReclassifiedWhy we changed it
Registry
Overweight — the first condition term the registry derived for this study.
ClinicalTrials.gg
Obesity
Why
  1. The study's listed conditions name Obesity, a narrower term within Overweight.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Norwegian University of Science and Technology · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
18 Years to 50 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 38 studies in Obesity by Norwegian University of Science and Technology — none open to participants now, 3 under way, none of them phase 3. Obesity · Norwegian University of Science and Technology.

Planned enrollment
5th of 37
100 · median 46
Started
2025
with 1 other
No phase
37 of 38
none open now
Registered
37th of 38
by date

Among the 38 studies in Obesity by Norwegian University of Science and Technology, this one is the 5th largest by planned enrollment of the 37 interventional ones that give a count, is one of 2 that started in 2025, is one of 37 with no phase, and was the 37th registered.

Obesity

11,564 studies on the registry are indexed under Obesity; 2,063 are open to participants now.

Browse Obesity studies →

Open to participants now

None of the 38 studies in Obesity by Norwegian University of Science and Technology is open now. The open studies under Obesity, anywhere →

Where they have run

Who these studies take

Of the 1,352 Obesity studies recruiting now, 382 (28%) set no upper age limit and 867 (64%) stop at 75 or younger; 169 take children under 18; 491 take healthy volunteers.

This study: 18 Years to 50 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Download CSVNarrow it in search →With an account: the 38 studies in Obesity by Norwegian University of Science and Technology as a file.
02

Study summary

This study will investigate the effects of 12 months periodised time-restricted eating combined with high-intensity interval training compared with a control group on fat mass in adults with overweight/obesity. Participants in the intervention group will complete the intervention remotely and will receive follow-up by telephone. Before randomisation, after 6 months and after 12 months, the investigators will measure the participants' body composition, physical fitness, fasting blood glucose and insulin, blood lipids, and blood pressure. Physical activity, diet, sleep quality, appetite, and adherence to the intervention will also be measured. Secondary sub-analyses of sex differences in the responses to the intervention will be performed.

03

Conditions studied

  • Overweight and Obesity

Browse trials for

Keywords

  • time-restricted eating
  • high-intensity interval training
  • exercise
  • diet
  • metabolic health
  • lifestyle intervention
04

In context

Obesity Reclassified

11,564 studies on the registry are indexed under Obesity; 2,063 are open to participants now.

This study's planned enrollment of 100 is above the median of 67 across 9,043 interventional studies indexed under Obesity.

Browse Obesity studies →

Lead sponsor

Norwegian University of Science and Technology is the lead sponsor of 495 studies on the registry; 47 are open to participants now.

Compared within Obesity, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Overweight. The counts are of registry records indexed under each term, refreshed daily. How we classify →

05

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • ≥ 27 kg/m²
  • Able to walk or ride a bike > 60 min

Exclusion criteria

Exclusion Criteria:

  • On-going pregnancy
  • Lactation within 24 weeks of study commencement
  • High-intensity exercise ≥ 1/week
  • Habitual eating window ≤12 hours/day
  • Taking hypertension, glucose-, or lipid-lowering drugs
  • Body mass variation ≥ 4 kg three months prior to study commencement
  • Known diabetes mellitus (type 1 or 2) or cardiovascular disease
  • Working night shifts
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

06

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
100 participants (estimated)

Study arms

  • Experimental
    Time-restricted eating and high-intensity interval training

    12 months of periodised time-restricted eating and high-intensity interval training with digital follow-up

    Behavioral: Time-restricted eating and high-intensity interval training

  • No intervention
    Control

    No intervention or follow-up. Habitual lifestyle

Interventions

  • BehavioralTime-restricted eating and high-intensity interval training

    1-month intense periods of maximal daily eating window of 10 hours and high-intensity interval training (three weekly, unsupervised, aerobic exercise sessions performed at \> 90 % heart rate maximum), separated by 3-month maintenance periods of time-restricted eating on 5 days per week and minimum 1 HIIT session per week. Each exercise session will last for 33-38 minutes. Participants will receive digital follow-up once weekly during intense periods, and once monthly during maintenance periods. The intervention period will be 12 months in total.

07

What researchers measure

Primary outcomes

  1. Total fat mass

    Change in total fat mass measured with bioelectrical impedance analysis

    Time frame: From baseline to after 12 months

Secondary outcomes

  1. Blood glucose

    Fasting concentration of plasma glucose

    Time frame: From baseline to after 6 months and after 12 months

  2. Total fat mass

    Change in total fat mass measured with bioelectrical impedance analysis

    Time frame: From baseline to after 6 months

  3. Insulin

    Fasting concentration of plasma insulin C-peptide

    Time frame: From baseline to after 6 months and after 12 months

  4. Average glucose levels

    Glycated haemoglobin (HbA1c)

    Time frame: From baseline to after 6 months and after 12 months

  5. Blood cholesterol

    Total fasting cholesterol in blood

    Time frame: From baseline to after 6 months and after 12 months

  6. LDL-cholesterol

    Fasting low-density lipoprotein-cholesterol in blood

    Time frame: From baseline to after 6 months and after 12 months

  7. HDL-cholesterol

    Fasting high-density lipoprotein-cholesterol in blood

    Time frame: From baseline to after 6 months and after 12 months

  8. Triglycerides

    Fasting triglycerides in blood

    Time frame: From baseline to after 6 months and after 12 months

  9. Cardiorespiratory fitness

    Peak oxygen uptake at a maximum effort test, measured in mL/min/kg and L/min

    Time frame: From baseline to after 6 months and after 12 months

  10. Insulin sensitivity

    Homeostatic model assessment for insulin resistance (HOMA-IR): 1.5 + fasting plasma glucose (mmol/L) x fasting plasma insulin C-peptide (pmol/L)/2800

    Time frame: From baseline to after 6 months and after 12 months

  11. Body mass

    In kg, estimated with bioelectrical impedance analysis

    Time frame: From baseline to after 6 months and after 12 months

  12. Fat-free mass

    In kg, estimated with bioelectrical impedance analysis

    Time frame: From baseline to after 6 months and after 12 months

  13. Visceral fat area

    In cm2, estimated with bioelectrical impedance analysis

    Time frame: From baseline to after 6 months and after 12 months

  14. Systolic blood pressure

    Average of three measurements during rest in seated position, in mmHg

    Time frame: From baseline to after 6 months and after 12 months

  15. Diastolic blood pressure

    Average of three measurements during rest in seated position, in mmHg

    Time frame: From baseline to after 6 months and after 12 months

  16. Resting heart rate

    Average of three measurements during rest in sitting position, in beats/min

    Time frame: From baseline to after 6 months and after 12 months

  17. Physical activity levels

    International Physical Activity Questionnaire

    Time frame: From baseline to after 6 months and after 12 months

  18. Diet intake

    3-day diet diaries (two weekdays and one weekend day) with online diet diary.

    Time frame: During baseline week, after 4, 13, 30, and 50 weeks.

  19. Sleep quality

    The Pittsburgh Sleep Quality Index questionnaire

    Time frame: From baseline to after 6 months and after 12 months

Other outcomes

  1. Adherence to high-intensity interval training

    Number of completed exercise sessions out of those prescribed, in percentage

    Time frame: 12 months

  2. Compliance to high-intensity interval training

    Exercise intensity measured with pulse sensor. Heart rate percentage of individual heart rate maximum.

    Time frame: 12 months

  3. Adherence to time-restricted eating

    Average number of days per week a daily eating window of 10 hours or less was achieved

    Time frame: During baseline week, after 4, 13, 30, and 50 weeks.

  4. Compliance to time-restricted eating

    Average daily eating window, self-reported in hours/day

    Time frame: During baseline week, after 4, 13, 30, and 50 weeks.

  5. Perception of intervention and digital follow-up

    Qualitative interviews with selected participants to explore barriers and motivators

    Time frame: After 12 months

  6. Sex differences

    Sub-analyses of sex differences in the effectiveness of the intervention

    Time frame: From baseline to after 6 months and after 12 months

08

Study locations

1 site
09

References and documents

Individual participant data

Plan to share: Yes — We will make de-identified individual participant data (IPD) collected in the study available to other researchers. We will upload a data set in an open access repository. We will only share IPD that cannot be used to identify individuals.

Supporting information: Study protocol, Statistical analysis plan, Clinical study report, Analytic code

Time frame: The data will become available at the time of publication of the results from the study.

Access criteria: Open access

No publications or documents are linked to this record.

10

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Sep 2025 (actual). Primary completion is estimated for Jul 2027, 22 months after the start.

Of 3,697 non-industry interventional studies with no phase under Obesity, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 43. This study's planned 22 months is close to that.

Counting every sponsor, half of 3,861 studies reached it within 22 months; a quarter within 9 and three quarters within 42.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 17, 2025
First posted
Jun 25, 2025
StartActual
Sep 11, 2025
Primary completionEst.
Jul 2027
CompletionEst.
Jul 2027
Last update
Aug 13, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 13, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT07036562
Responsible party
Sponsor
First posted
Jun 25, 2025
Start date
Sep 11, 2025
Primary completion
Jul 2027 (estimated)
Completion
Jul 2027 (estimated)
Last update
Aug 13, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion